论文部分内容阅读
据报道,接受血管紧张素转换酶抑制剂治疗者的3～15％有咳嗽的副作用。在治疗6月发生者约占36％,18月后增至15％,长期治疗者的6％因咳嗽副作用而停药。作者晚近报告1例以色苷酸钠有效地控制了血管紧张素转换酶抑制剂诱发的干咳。
It has been reported that 3 to 15% of those receiving angiotensin converting enzyme inhibitor have a side effect of cough. About 36% of those treated in June and 15% after 18 months, 6% of chronically treated patients discontinued due to coughing side effects. The authors recently reported that 1 case of sodium acetate effectively controlled angiotensin-converting enzyme inhibitor-induced dry cough.